ProShares Ultra Nasdaq Biotechnology BIB:NASDAQ

Last Price$50.00NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/24/19

Today's Change-2.16(4.14%)
Bid (Size)$49.76 (7)
Ask (Size)$50.60 (10)
Day Low / High$49.80 - 52.11
Volume159.8 K
 

View portfolioPortfolio as of 04/30/2019

Top 5 SectorsTop 5 Holdings
Health Technology95.89%
Celgene Corp ORD8.41%
Commercial Services1.12%
Gilead Sciences Inc ORD8.33%
Health Services0.73%
Amgen Inc ORD7.86%
Other0.28%
Biogen Inc ORD5.71%
Distribution Services0.15%
Vertex Pharmaceuticals Inc ORD5.47%
Concentration of Top 598.17% Concentration of Top 535.78% 

Fund Profile

Fund Strategy

The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.

Fund Category Sector Equity
Inception Date 04/07/2010
Manager Neches/Dave
Fund Classification Equity Leverage Funds
Managed Since 2013
Other Managed Funds   UYG  ROM  INPIX  BIPIX  TEPIX

Lipper Leader Scorecard as of 05/31/2019

RatingTotal
Return
Consistent
Return
PreservationTax
Efficiency
Expense*
Overall Rating(# of funds in category)
172

169

12,207

189

68
3 Year Rating(# of funds in category)
172

170

12,207

189

68
5 Year Rating(# of funds in category)
154

152

10,358

160

58
10 Year Rating(# of funds in category)
N/A

N/A

N/A

N/A

N/A

Fund Highlights

Price Open$52.11
Previous Close$52.16
52 Week Range$36.05 - 70.82
Average Market Capitallization225.0 M
Shares Outstanding4.5 M
Net Asset ValueN/A
Total Net Assets$207.5 M
Total Expense Ratio0.95

Options Summary

Call Open Interest (1d)
Put Open Interest (1d)
Call Volume (1d)
Put Volume (1d)
Put Call Open Interest Ratio (1d)
Put Call Volume Ratio (1d)

Risk Analysis

Beta vs. S&P 5002.86
R-Squared vs. S&P 5000.56
Standard Deviation44.02%
Sharpe Ratio0.14